In 15 patients (28%), the location of the SLNs designated for biopsy by lymphoscintigraphy were first marked on the overlying skin with the handheld gamma-camera and a 57Co-penpoint marker using its dual-isotope function (Fig. 4). Then, with the patient in a similar position, the location of the identified SLNs were marked using the conventional gamma-camera (Siemens Symbia T16 system) and the 57Co-penpoint marker, according to standard protocol. Subsequently, the location of both cutaneous markings were compared, with cutaneous markings based on the conventional gamma-camera as reference standard. The marked location of SLNs using the handheld gamma-camera was considered accurate if they deviated ≤ 10 mm in any direction from the location as marked with the conventional gamma-camera.

a Cutaneous marking of the location of SLNs using Crystal Cam handheld gamma-camera and a 57Co-penpoint marker. To simulate the definite surgical position, the patient is placed in supine position with head slightly extended and rotated to the opposite side. b Separate 57Co-hotspot (57Co) and 99mTc-hotspot (99mTc) within the handheld gamma-camera’s field-of-view. (c) Overlapping 57Co-hotspot and 99mTc-hotspot, indicating that the 57Co-penpoint marker is positioned on the SLN’s location

Free full text: Click here